Derivados de Quinazolina e Quinolina
As quinazolinas e quinolinas são compostos heterocíclicos contendo nitrogénio, com estruturas aromáticas que desempenham um papel fundamental na síntese de fármacos com atividade anticancerígena, antimicrobiana e anti-inflamatória. Os seus derivados apresentam modificações estruturais que otimizam a biodisponibilidade e a seletividade, permitindo o desenvolvimento de novos princípios ativos para diversas aplicações terapêuticas. Estes compostos são utilizados na fabricação de APIs para o tratamento do câncer, infeções, doenças neurodegenerativas e cardiovasculares. Além disso, os derivados de quinazolina e quinolina são essenciais na investigação de inibidores enzimáticos e no desenvolvimento de moléculas bioativas inovadoras.
Na CymitQuimica, oferecemos derivados de quinazolina e quinolina de alta pureza para aplicações em síntese química, desenvolvimento farmacêutico e biotecnologia.
Foram encontrados 65580 produtos de "Derivados de Quinazolina e Quinolina"
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
Oxcarbazepine Related Compound D (10-(10-Oxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamido)-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C30H22N4O3Cor e Forma:Light Yellow Yellow PowderPeso molecular:486.16919Fluphenazine Decanoate Dihydrochloride
CAS:Antidepressants, tranquilizers and other pschotherapeutic agentsFórmula:C32H44F3N3O2S·2HClCor e Forma:White PowderPeso molecular:663.26399Rivaroxaban Related Compound G ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H19N3O6Cor e Forma:White Off-White SolidPeso molecular:421.12739Carvedilol Related Compound D (4-(Oxiran-2-ylmethoxy)-9H-carbazole)
CAS:Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFórmula:C15H13NO2Cor e Forma:Light Yellow PowderPeso molecular:239.09463N-Nitroso Carvedilol Solution (1 mL ) (N-(3-((9H-carbazol-4-yl)oxy)-2-hydroxypropyl)-N-(2-(2-methoxyphenoxy)ethyl)nitrous amide)
CAS:Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiFórmula:C24H25N3O5Cor e Forma:LiquidPeso molecular:435.179425-Hydroxymethylfurfural (5-(Hydroxymethyl)-2-furaldehyde)
CAS:Compounds containing an unfused furan ring, whether or not hydrogenated, in the structure, nesoiFórmula:C6H6O3Cor e Forma:Yellow SolidPeso molecular:126.03169Rivaroxaban Desthiophene Analog ((R)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C14H17N3O4Cor e Forma:White Off-White SolidPeso molecular:291.12191Rivaroxaban N-acyl glycolic acid ((S)-2-(2-(5-chloro-N-(4-(5-((5-chlorothiophene-2-carboxamido)methyl)-2-oxooxazolidin-3-yl)phenyl)thiophene-2-carboxamido)ethoxy)acetic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C24H21Cl2N3O7S2Cor e Forma:Off-White SolidPeso molecular:597.0198Sildenafil Related Compound A (1-{[3-(6,7-Dihydro-1-methyl-7-oxo-3-isobutyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazine)
CAS:Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFórmula:C23H32N6O4SCor e Forma:White PowderPeso molecular:488.22057R,R,S-Ezetimibe ((3R,4S)-1-(4-fluorophenyl)-3-((R)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one)
CAS:Lactams not elsewhere specified or includedFórmula:C24H21F2NO3Cor e Forma:White Off-White SolidPeso molecular:409.14895Ambrisentan Related Compound D (2-[(2,2-Diphenylvinyl)oxy]-4,6-dimethylpyrimidine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFórmula:C20H18N2OCor e Forma:Off-White Fine PowderPeso molecular:302.14191Silodosin S-Enantiomer
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C25H32F3N3O4Cor e Forma:White Off-White Crystalline PowderPeso molecular:495.23449Aripiprazole Related Compound F (4-(2,3-dichlorophenyl)-1-[4-(2-oxo-1,2,3,4-tetrahydroquinolin-7-yloxy)butyl]piperazin 1-oxide)
CAS:Lactams not elsewhere specified or includedFórmula:C23H27Cl2N3O3Cor e Forma:White Light Yellow PowderPeso molecular:464.39Omeprazole Related Compound E (4-Methoxy-2-[[(RS)-(5-methoxy-1H-benzimidazol-2-yl)sulfinyl]methyl]-3,5-dimethylpyridine 1-oxide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C17H19N3O4SCor e Forma:Off-White PowderPeso molecular:361.10963Fluphenazine Enanthate Dihydrochloride
CAS:Antidepressants, tranquilizers and other pschotherapeutic agentsFórmula:C29H38F3N3O2S·2HClCor e Forma:PowderPeso molecular:549.26368Diphthalimido Morpholinone Analog (2,2'-((2R,2'R)-((4-(3-oxomorpholino)phenyl)azanediyl)bis(2-hydroxypropane-3,1-diyl))bis(isoindoline-1,3-dione))
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C32H30N4O8Cor e Forma:Pale Yellow SolidPeso molecular:598.20636Carvedilol Related Compound B (3,3'-(2-(2-methoxyphenoxy)ethylazanediyl)bis(1-(9H-carbazol-4-yloxy)propan-2-ol))
CAS:Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFórmula:C39H39N3O6Cor e Forma:Off-White PowderPeso molecular:645.28389Labetalol Cyclohexyl Analog (5-{2-[(4-Cyclohexylbutan-2-yl)amino]-1-hydroxyethyl}-2-hydroxybenzamide hydrochloride)
CAS:Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFórmula:C19H30N2O3·HClCor e Forma:White PowderPeso molecular:370.20232Rotigotine Hydrochloride ((6S )-6-[Propyl(2-(2-thienyl)ethyl)amino]-5,6,7,8-tetrahydronaphthalen-1-ol hydrochloride)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C19H25NOSHClCor e Forma:White Off-White PowderPeso molecular:315.16569O-Desmethyl Apremilast ((S)-N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide)
CAS:Other aromatic organo-sulfur compounds (excluding pesticides)Fórmula:C21H22N2O7SCor e Forma:Pale Yellow SolidPeso molecular:446.11477Bupropion Hydrochloride Related Compound A (2-(tert-butylamino)-4'-chloropropiophenone hydrochloride)
CAS:Amino-aldehydes, amino-ketones and amino-quinones, other than those containing more than one kind of oxygen function; salts thereof, nesoiFórmula:C13H18ClNO·HClCor e Forma:White PowderPeso molecular:275.08437Fluconazole Related Compound A (2-[2-fluoro-4-(1H-1,2,4-triazol-1-yl)phenyl]-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ol)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C15H14FN9OCor e Forma:White PowderPeso molecular:355.13053Plerixafor System Suitability Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White Off-White SolidParoxetine System Suitability Mixture A
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCor e Forma:White Off-White PowderAtazanavir Dipeptide Analog (methyl ((5S,8S,13S,14S,17S)-14-benzyl-5,8-di-tert-butyl-13-hydroxy-18,18-dimethyl-3,6,9,16-tetraoxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,10,11,15-pentaazanonadecan-17-yl)carbamate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C44H63N7O8Cor e Forma:SolidPeso molecular:817.473812-Vinylpyridine (2-Ethenylpyridine)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C7H7NCor e Forma:Light Brown LiquidPeso molecular:105.14 g/molDasatinib Related Compound B (N-(2-Chloro-6-methylphenyl)-2-{[2-methyl-6-(piperazin-1-yl)pyrimidin-4-yl]amino}thiazole-5-carboxamide)
CAS:Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFórmula:C20H22ClN7OSCor e Forma:White Off-White PowderPeso molecular:443.12951Topiramate
CAS:Sulfonamides used as drugsFórmula:C12H21NO8SCor e Forma:White Off-White Crystalline PowderPeso molecular:339.09879Ondansetron Related Compound C (9-Methyl-1,2,3,9-tetrahydro-4H-carbazol-4-one)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C13H13NOCor e Forma:White Powder ClumpyPeso molecular:199.09971Fluvoxamine Maleate
CAS:Aromatic organic derivatives of hydrazine or of hydroxylamineFórmula:C15H21F3N2O2·C4H4O4Cor e Forma:White Off-White Crystalline PowderPeso molecular:318.15551Sodium Starch Glycolate Type A
CAS:Modified starches, nesoiFórmula:(C2H4O3)x·(Na)xCor e Forma:White Off-White PowderPeso molecular:515.6862Rotigotine Related Compound H ((S)-5-Methoxy-N-propyl-N-[2-(thiophen-2-yl)ethyl]-1,2,3,4-tetrahydronaphthalen-2-amine)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C20H27NOSCor e Forma:Light Brown LiquidPeso molecular:329.18134Naproxen Related Compound G ((R)-2-(6-Methoxynaphthalen-2-yl)propanoic acid)
CAS:Carboxylic acids with additional oxygen function and their anhydrides, halides, peroxides etc not elsewhere specified or includedFórmula:C14H14O3Cor e Forma:PowderPeso molecular:230.09429Clozapine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFórmula:C18H19ClN4Cor e Forma:Yellow PowderPeso molecular:326.12982Anastrozole Diacid (2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanoic acid))
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFórmula:C17H21N3O4Cor e Forma:Off-White SolidPeso molecular:331.15321O-Thienylethyl Rotigotine Hydrochloride ((S)-N-propyl-5-(2-(thiophen-2-yl)ethoxy)-N-(2-(thiophen-2-yl)ethyl)-1,2,3,4-tetrahydronaphthalen-2-amine hydrochloride)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C25H32ClNOS2Cor e Forma:Pale Beige SolidPeso molecular:461.16138Teriflunomide Related Compound B (2-Cyano-N-(4-(trifluoromethyl)phenyl)acetamide)
CAS:Nitrile function compounds, nesoiFórmula:C10H7F3N2OCor e Forma:White Yellow Crystalline PowderPeso molecular:228.05105Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS:Toluidines (aminotoluenes) and their derivatives, salts thereofFórmula:C7H6F3NCor e Forma:White Light Yellow LiquidPeso molecular:161.04523Bicalutamide Related Compound A (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide)
Other aromatic organo-sulfur compounds (excluding pesticides)Cor e Forma:PowderPeso molecular:414.38Ofloxacin
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C18H20FN3O4Cor e Forma:Off-White Pale Yellow PowderPeso molecular:361.14378Metoprolol Tartrate
CAS:Aromatic drugs of amino-alcohols, other than those contg more than one kind of oxygen function, their ethers and esters; salts thereof, nesoiFórmula:C15H25NO3C4H6O6Cor e Forma:White Crystalline PowderPeso molecular:684.81Rivaroxaban Desmorpholinone Analog ((S)-5-chloro-N-((3-(4-((2-hydroxyethyl)amino)phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H18ClN3O4SCor e Forma:White Off-White SolidPeso molecular:395.07065Duloxetine Related Compound H ((S)-4-{Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino}-4-oxobutanoic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C22H23NO4SCor e Forma:White Crystalline PowderPeso molecular:397.13478Clozapine Resolution Mixture
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureCor e Forma:Yellow Crystalline PowderPeso molecular:203.09061Ofloxacin Related Compound A (9-Fluoro-3-methyl-7-oxo-10-(piperazin-1-yl)-2,3-dihydro-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C17H18FN3O4Cor e Forma:Light Yellow PowderPeso molecular:347.12813Fluconazole
CAS:Anti-infective agents, nesoiFórmula:C13H12F2N6OCor e Forma:White Off-White PowderPeso molecular:306.10407Copovidone
CAS:Vinyl copolymers in primary forms, nesoiFórmula:(C6H9NO)n(C4H6O2)mCor e Forma:White Yellow PowderPeso molecular:197.23 g/molChloro N-methylthiophene Carboxamide (5-chloro-N-methylthiophene-2-carboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFórmula:C6H6ClNOSCor e Forma:White Off-White SolidPeso molecular:174.98586Betahistine Hydrochloride
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFórmula:C8H12N2·2HCICor e Forma:White Light Yellow Crystalline PowderPeso molecular:415.92464
![Duloxetine Related Compound H ((S)-4-{Methyl[3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amino}…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1229883.webp&w=3840&q=75)
